Stephen G Henry1,2, Melissa M Gosdin3, Anne E C White4,3, Richard L Kravitz4,3. 1. Department of Internal Medicine, University of California, Davis, Sacramento, CA, USA. sghenry@ucdavis.edu. 2. Center for Healthcare Policy and Research, University of California, Davis, Sacramento, CA, USA. sghenry@ucdavis.edu. 3. Center for Healthcare Policy and Research, University of California, Davis, Sacramento, CA, USA. 4. Department of Internal Medicine, University of California, Davis, Sacramento, CA, USA.
Abstract
BACKGROUND: Physicians' fear of difficult patient interactions is an important barrier to discontinuing long-term opioid therapy. OBJECTIVE: To identify patient statements about opioids that indicate potential openness to tapering opioids or trying non-opioid pain treatments DESIGN: This is an observational study of regularly scheduled primary care visits involving discussion of chronic pain management. A coding system to characterize patient assessments about opioids, physician responses to assessments, and patient-endorsed opioid side effects was developed and applied to transcripts of video-recorded visits. All visits were independently coded by 2 authors. PARTICIPANTS: Eighty-six established adult patients taking opioids for chronic pain; 49 physicians in 2 academic primary care clinics MAIN MEASURES: Frequency and topic of patients' opioid assessments; proportion of opioid assessments classified as clues (assessments indicating potential willingness to consider non-opioid pain treatments or lower opioid doses); physician responses to patient clues; frequency and type of patient-endorsed side effects KEY RESULTS: Patients made a mean of 3.2 opioid assessments (median 2) per visit. The most common assessment topics were pain relief (51%), effect on function (21%), and opioid safety (14%). Forty-seven percent of opioid assessments (mean 1.5 per visit) were classified as clues. Fifty-three percent of visits included ≥ 1 clue; 21% of visits contained ≥ 3 clues. Physicians responded to patient clues with no/minimal response 43% of the time, sympathetic/empathetic statements 14% of the time, and further explored clues 43% of the time. Fifty-eight percent of patients endorsed ≥ 1 opioid-related side effect; 10% endorsed ≥ 3 side effects. The most commonly endorsed side effects were constipation (15% of patients), sedation (15%), withdrawal symptoms (13%), and nausea (12%). CONCLUSIONS: Patient statements suggesting openness to non-opioid pain treatments or lower opioid doses are common during routine primary care visits. Listening for and exploring these clues may be a patient-centered strategy for broaching difficult topics with patients on long-term opioid therapy.
BACKGROUND: Physicians' fear of difficult patient interactions is an important barrier to discontinuing long-term opioid therapy. OBJECTIVE: To identify patient statements about opioids that indicate potential openness to tapering opioids or trying non-opioid pain treatments DESIGN: This is an observational study of regularly scheduled primary care visits involving discussion of chronic pain management. A coding system to characterize patient assessments about opioids, physician responses to assessments, and patient-endorsed opioid side effects was developed and applied to transcripts of video-recorded visits. All visits were independently coded by 2 authors. PARTICIPANTS: Eighty-six established adult patients taking opioids for chronic pain; 49 physicians in 2 academic primary care clinics MAIN MEASURES: Frequency and topic of patients' opioid assessments; proportion of opioid assessments classified as clues (assessments indicating potential willingness to consider non-opioid pain treatments or lower opioid doses); physician responses to patient clues; frequency and type of patient-endorsed side effects KEY RESULTS:Patients made a mean of 3.2 opioid assessments (median 2) per visit. The most common assessment topics were pain relief (51%), effect on function (21%), and opioid safety (14%). Forty-seven percent of opioid assessments (mean 1.5 per visit) were classified as clues. Fifty-three percent of visits included ≥ 1 clue; 21% of visits contained ≥ 3 clues. Physicians responded to patient clues with no/minimal response 43% of the time, sympathetic/empathetic statements 14% of the time, and further explored clues 43% of the time. Fifty-eight percent of patients endorsed ≥ 1 opioid-related side effect; 10% endorsed ≥ 3 side effects. The most commonly endorsed side effects were constipation (15% of patients), sedation (15%), withdrawal symptoms (13%), and nausea (12%). CONCLUSIONS:Patient statements suggesting openness to non-opioid pain treatments or lower opioid doses are common during routine primary care visits. Listening for and exploring these clues may be a patient-centered strategy for broaching difficult topics with patients on long-term opioid therapy.
Authors: Stephen G Henry; Anthony Jerant; Ana-Maria Iosif; Mitchell D Feldman; Camille Cipri; Richard L Kravitz Journal: Patient Educ Couns Date: 2015-03-17
Authors: Benjamin J Morasco; Bobbi Jo Yarborough; Ning X Smith; Steven K Dobscha; Richard A Deyo; Nancy A Perrin; Carla A Green Journal: J Pain Date: 2016-12-18 Impact factor: 5.820
Authors: Laura C Kennedy; Ingrid A Binswanger; Shane R Mueller; Cari Levy; Daniel D Matlock; Susan L Calcaterra; Stephen Koester; Joseph W Frank Journal: Pain Med Date: 2018-11-01 Impact factor: 3.750
Authors: Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell Journal: MMWR Morb Mortal Wkly Rep Date: 2017-07-07 Impact factor: 17.586
Authors: Stephen G Henry; Anne Elizabeth Clark White; Elizabeth M Magnan; Eve Angeline Hood-Medland; Melissa Gosdin; Richard L Kravitz; Peter Joseph Torres; Jennifer Gerwing Journal: Patient Educ Couns Date: 2020-06-03